Inhibition of Aβ Aggregation by Cholesterol-End-Modified PEG Vesicles and Micelles

<b>Background/Objectives</b>: This study aimed to design and evaluate Chol-PEG₂₀₀₀ micelles and Chol-PEG₅₀₀ vesicles as drug delivery system (DDS) carriers and inhibitors of amyloid-β (Aβ) aggregation, a key factor in Alzheimer’s disease (AD). <b>Methods</b>: The physical prope...

Descrición completa

Detalles Bibliográficos

Principais autores:	Shota Watanabe, Motoki Ueda, Shoichiro Asayama
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2024-12-01
Series:	Pharmaceutics
Assuntos:	Alzheimer’s disease Aβ aggregation drug delivery carrier micelle vesicle cholesterol-end-modified PEG (Chol-PEG)
Acceso en liña:	https://www.mdpi.com/1999-4923/17/1/1
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!